Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Proton pump

A proton pump is an integral membrane protein pump that builds up a proton gradient across a biological membrane.During evolution, proton pumps have arisen independently on multiple occasions. Thus, not only throughout nature but also within single cells, different proton pumps that are evolutionarily unrelated can be found. Proton pumps are divided into different major classes of pumps that use different sources of energy, have different polypeptide compositions and evolutionary origins.

Bafilomycin A1
T674088899-55-2
Bafilomycin A1 belongs to the macrolide class of antibiotics and is a V-ATPase inhibitor (IC50=0.44 nM) that is specific and reversible. Bafilomycin A1 is an inhibitor of the late phase of autophagy, blocking the fusion of autophagosomes with lysosomes. Bafilomycin A1 also induces apoptosis.
  • $195
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Chebulinic acid
TQ018418942-26-2
Chebulinic acid is a potent inhibitor of M. tuberculosis DNA gyrase. It also can inhibit SMAD-3 phosphorylation and H+ K+-ATPase activity.
  • $67
In Stock
Size
QTY
Abscisic Acid
T636821293-29-8
Abscisic Acid (Dormin) is a plant hormone, which is involved in many plant developmental processes, modulates ion homeostasis and metabolism, and inhibits germination and seedling growth.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
SKF96067
T16894115607-61-9In house
SKF96067 is a reversible gastric H+/K+-ATPase inhibitor that can induce relaxation of human airway smooth muscle in vitro.
  • $293
In Stock
Size
QTY
Tiludronate disodium
T13159149845-07-8In house
Tiludronate disodium (Tiludronic acid disodium) is an osteoclast vacuolar H(+)-ATPase inhibitor with antiresorptive and anti-inflammatory properties. Tiludronate disodium can be used in studies about metabolic bone disorders.
  • $73
In Stock
Size
QTY
AGN-201904
T23667651729-53-2In house
AGN-201904 is an omeprazole prodrug and proton pump inhibitor, which may delay aging and be used for the prevention and treatment of peptic ulcers.
  • $293
In Stock
Size
QTY
Saviprazole
T28665121617-11-6In house
Saviprazole (Hoe-731), a proton pump inhibitor, is used potentially for treatment of gastric ulcer.
  • $143
In Stock
Size
QTY
Protonstatin-1
T71812521972-99-6
Protonstatin-1 is used as a hypoglycemic agent and as a compound for the treatment of Alzheimer's disease, inhibits IGFIR kinase activity and can be used in cancer research.
  • $97
In Stock
Size
QTY
Caloxin 2A1 TFA
T35923
Caloxin 2A1 TFA is a novel PM Ca2+ pump inhibitor. It inhibits human red blood cell Ca2+-Mg2+-ATPase, blocking Ca2+ dependent formation of a 140-kDa acid-stable acylphosphate.
  • $42
In Stock
Size
QTY
Omeprazole
T075773590-58-6
Omeprazole (Losec) is a proton pump inhibitor (PPI), Omeprazole(Losec) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor).
  • $40
In Stock
Size
QTY
TargetMol | Citations Cited
Pumaprazole
T16682158364-59-1
Pumaprazole (BY-841) is an antagonist of a reversible proton pump.
  • $84
In Stock
Size
QTY
EN6
T111911808714-73-9
EN6-mediated ATP6V1A modification decouples the v-ATPase from the Rags, leading to inhibition of mTORC1 signaling, increased lysosomal acidification and activation of autophagy. EN6 clears TDP-43 aggregates, a causative agent in frontotemporal dementia, in a lysosome-dependent manner. EN6 is a small-molecule in vivo activator of autophagy that covalently targets cysteine 277 in the ATP6V1A subunit of the lysosomal the vacuolar H+ ATPase (v-ATPase).
  • $39
In Stock
Size
QTY
WY-47766
T29164134217-27-9In house
WY-47766 (OST-766) is a small molecule proton pump inhibitor that can be used to study postmenopausal osteoporosis.
  • $293 TargetMol
In Stock
Size
QTY
Soraprazan
T12977261944-46-1In house
Soraprazan (BYK61359) is a selective potassium channel inhibitor that inhibits gastric acid secretion and ameliorates age-related eye disease by removing lipofuscin from retinal pigment epithelial (RPE) cells.
  • $155
In Stock
Size
QTY
Zinc pyrithione
T050213463-41-7
Zinc pyrithione (OM-1563), an antibacterial and antifungal agent can disrupt membrane transport by blocking the proton pump.
  • $35
In Stock
Size
QTY
Thonzonium Bromide
T2188553-08-2
Thonzonium bromide is a mono-cationic surfactant that is structurally similar to Farnesol as an antimicrobial agent. It inhibits proton transport in a dose-dependent manner (EC50=69 μM). It inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo.
  • $30
In Stock
Size
QTY
Caloxin 2A1 acetate
T40437L
Caloxin 2A1 acetate is an inhibitor of extracellular plasma membrane Ca2+-ATPase (PMCA) peptide. Caloxin 2A1 acetate inhibits Ca2+-dependent formation of the 140-kDa acid-stable acylphosphate.
  • $50
In Stock
Size
QTY
FR-167356
T27371174185-16-1In house
FR-167356 is a specific inhibitor of a3 isoform vacuolar type H⁺-ATPase with IC50s of 170 nM, 370 nM and 220 nM for osteoclast plasma membranes, renal brush border membranes and macrophage microsomes. FR-167356 reduces bone metastasis of B16-F10 cells.
  • $118
In Stock
Size
QTY
Lansoprazole sulfone
T20155131926-99-3
Lansoprazole sulfone is a metabolite of the gastric pump inhibitor Lansoprazole.
  • $48
In Stock
Size
QTY
Linaprazan
T10435248919-64-4In house
Linaprazan (AZD0865) inhibits gastric H+,K+-ATPase through K+-competitive binding, with an IC50 of 1.0 μM.
  • $43
In Stock
Size
QTY
Abeprazan hydrochloride
T102211902954-87-3In house
Abeprazan hydrochloride (Fexuprazan hydrochloride) is an effective reversible potassium-competitive acid blocker with oral activity, inhibiting H+, K+ -atPase by competitive binding to potassium ions without acid activation. Abeprazan hydrochloride is a proton pump inhibitor (PPI) that acts by reducing gastric acid production and is used to treat gastric acid-related disorders, such as gastroesophageal reflux disease (GERD) and peptic ulcers.
  • $56
In Stock
Size
QTY
Pantoprazole
T6928102625-70-7
Pantoprazole (BY1023) is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.
  • $30
In Stock
Size
QTY
Tegoprazan
T17030942195-55-3
Tegoprazan is an orally active, highly selective gastric H+ K+-ATPase inhibitor that controls gastric acid secretion and motility, with an IC50 of 0.29-0.52 μM for porcine, canine, and human H+ K+-ATPase in vitro.
  • $48
In Stock
Size
QTY
Rabeprazole sodium
T1651117976-90-6
Rabeprazole sodium (Habeprazole Sodium) is a 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of stomach ulcers and Zollinger-Ellison syndrome. The drug inhibits H(+)-K(+)-exchanging ATPase which is found in gastric parietal cells.
  • $35
In Stock
Size
QTY